Albedo buys majority stake in Taiwanese aesthetic medicine group

Albedo buys majority stake in Taiwanese aesthetic medicine group

Visual from the company website

Albedo Limited, a Singapore-listed steel trading company, has bought a majority stake in a Taiwanese aesthetic medicine group.  Albedo said the acquisition would serve as a springboard for its expansion into China’s fast-growing healthcare market

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter